Security Resilience

CVE-2023-43991

Linecorp Line 13.6.1

Public PoC
Published
24 January 2024
Modified
30 May 2025
CVSS Score v3.1 5.4
Click a component to see what it means
Raw vectorCVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:L/I:L/A:N
EPSS Score 0.0039 32th percentile
Risk Priority 43 floored blend · peak EPSS

CVSS and EPSS are reproduced from their sources (NVD, FIRST EPSS). Risk Priority is our own derived reading, not an NVD score.

Summary

CVE-2023-43991 is a medium-severity an unspecified weakness vulnerability in Linecorp Line. Its CVSS base score is 5.4 (Medium).

Operationally, ranked at the 32th percentile by exploit likelihood (below the median); it is not currently listed in the CISA KEV catalog; a public proof-of-concept is referenced.

EU & UK References

Vulnerability Data

An issue in PRIMA CLINIC mini-app on Line v13.6.1 allows attackers to send crafted malicious notifications via leakage of the channel access token.

CWE(s)
NVD-CWE-noinfo

Related Threats

CVEs Like This One

CVE-2023-38849Same product: Linecorp Line
CVE-2023-45561Same product: Linecorp Line
CVE-2023-47365Same product: Linecorp Line
CVE-2025-14021Same product: Linecorp Line
CVE-2023-43297Same product: Linecorp Line
CVE-2023-47370Same product: Linecorp Line
CVE-2023-43993Same product: Linecorp Line
CVE-2023-48135Same product: Linecorp Line
CVE-2023-43995Same product: Linecorp Line
CVE-2023-43996Same product: Linecorp Line

Affected Assets

linecorp
line
13.6.1

Mitigating Controls

No mitigating controls mapped yet. The per-CVE control annotator has not reached this CVE.

References